Polomar Health Services, Inc. (PMHS)

Market Cap	8.42M
Revenue (ttm)	648.23K +1,002.0%
Net Income	-10.70M
EPS	-0.39
Shares Out	28.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	2,785
Open	0.3000
Previous Close	0.4000
Day's Range	0.3000 - 0.3000
52-Week Range	0.0654 - 0.7999
Beta	n/a
RSI	49.22
Earnings Date	May 22, 2026

About Polomar Health Services

Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, a...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2023
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMHS

Financial Performance

In 2025, Polomar Health Services's revenue was $648,231, an increase of 1001.98% compared to the previous year's $58,824. Losses were -$10.70 million, 697.8% more than in 2024.